September 26, 2020

The Niche

Knoepfler lab stem cell blog

Longeveron

4 min read

If you want to fight aging, should you turn to stem cells? Does the idea of stem cells to battle getting old even make any sense? The answer is, “it depends.” It’s a really interesting area conceptually and technically for stem cells. A theory. There is evidence that things that happen to our endogenous stem cells are linked to aging. In my book Stem Cells: An Insider’s Guide, which I’m hoping to get a new edition out for next year, I even proposed the …Read More

5 min read

Stem cells for flu? For me, that idea is new. Some months back there was buzz about the stem cell biotech Longeveron related to its report on early trial data on testing infusions of mesenchymal stem cells for frailty in the aged. Frailty that pops up in some aging folks can manifest in a variety of ways and contribute both to reduced quality of life and mortality. This week a PR firm for Longeveron sent out an email suggesting that the company’s investigational stem …Read More

3 min read

A team at the University of Miami has launched a claimed first of its kind stem cell clinic trial for Alzheimer’s Disease (AD). The trial seems somewhat unique in using mesenchymal stem cells (MSC) for AD and is being run with biotech Longeveron. You can read more on the actual clinic trial including all the pertinent details here. I was unable to find a website for the company, but it is described here. Another stem cell trial for AD was announced last year that drew …Read More